Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy
Clinical trial NCT01720901 · SUSPENDED
Trial details
- NCT number
- NCT01720901
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- SUSPENDED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2015-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.